Harvard College senior Mary Davies ’13 has been named a Global Health Fellow with Medical Missionaries.
Harvard College Dean Evelynn M. Hammonds discussed her book “The Nature of Difference: Sciences of Race in the United States from Jefferson to Genomics” before 50 students as part of Wintersession activities.
A novel experiment illuminates the importance of the doctor-patient relationship, providing the first data into the underlying neurobiology of the caregiver.
Researchers from Harvard-affiliated Brigham and Women’s Hospital have found that some patients who receive generic drugs that vary in their color are over 50 percent more likely to stop taking the drug, leading to potentially important and potentially adverse clinical effects.
Medical experts are coming to see cancer not as a disease of cells or even of genes, but as an “organismal disease,” Siddhartha Mukherjee, author of the Pulitzer Prize–winning cancer history “The Emperor of All Maladies,” told a Harvard Medical School audience on Oct. 11.
Researchers at Harvard-affiliated Brigham and Women’s Hospital have pinpointed when seemingly innocuous skin pigment cells mutate into melanoma.
Patrick O'Callahan has been named the new director of after-hours urgent care and the Stillman Infirmary at Harvard University Health Services.
HMS faculty Kenneth Anderson, Paul Richardson, and Alfred Goldberg are three of four researchers being honored for their research and development of a pioneering cancer drug.
The annual symposium of the Wyss Institute for Biologically Inspired Engineering, held at Harvard Medical School, prompted a spirited discussion on robotics and medicine, with nature as a model.
Sonya Soni always felt called to serve the Indian orphanage that her family has run for four generations. Two years at Harvard Divinity School challenged her to rethink what the struggling community needs most.
Nicholas Christakis, whose research explores how everything from obesity to smoking to happiness spreads among our social networks, is turning his attention to the past, exploring why and how we became the social animals we are.
Harvard Medical School Professor of Medicine Russell S. Phillips has been appointed inaugural director of HMS’s Center for Primary Care by Jeffrey S. Flier, dean of the faculty of medicine.
Harvard researchers and clinicians collaborate across disciplines and around the globe to craft solutions to the world’s toughest health challenges.
The Harvard Club of Australia Foundation has announced fellowship awards to eight accomplished Harvard researchers intending collaborative scientific research in Australia during 2012, and to two Australian researchers headed to Harvard.
Susan Greenhalgh, a new professor in Harvard’s anthropology department, studies China’s controversial one-child policy, finding lessons for American health policymakers, too.
For roughly 2,000 years, Chinese herbalists have treated malaria using a root extract, commonly known as chang shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, a compound derived from this extract’s bioactive ingredient, could be used to treat many autoimmune disorders as well. Now, researchers from the Harvard School of Dental Medicine have discovered the molecular secrets behind this herbal extract’s power.
In his new memoir, former Harvard Medical School Dean Joseph Martin recalls a small-town childhood, an attraction to medicine, and the ups and downs of leadership.
At the first Harvard Thinks Green, six Harvard professors gathered at Sanders Theatre to seek big solutions for complex and potentially intractable problems such as climate change.
In a study that seems to pivot on a paradox, scientists at Harvard-affiliated Dana-Farber Cancer Institute have used an immune system stimulant as an immune system suppressor to treat a common, often debilitating side effect of donor stem cell transplantation in cancer patients. The effect, in some cases, was profound.
Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School is launching the Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists, and clinicians to explore together how drugs work in complex systems.
Physician and historian David Jones works to bridge the gap between medical science and the social forces that shape it, as Harvard’s first A. Bernard Ackerman Professor of the Culture of Medicine.
Bioengineers at Harvard have, for the first time, explained how the blast of an exploding bomb can translate into subtly disastrous injuries in the nerve cells and blood vessels of the brain.
Dermatologist Robert Sackstein has been awarded a prestigious $17 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health.
Scientists from around New England gathered at the Broad Institute of MIT and Harvard to discuss the latest research and findings about tuberculosis at the Fifth Annual New England Tuberculosis Symposium.
Harvard University’s Sharad Ramanathan, assistant professor of molecular and cellular biology, has been named a Pew Scholar in the Biomedical Sciences.
During a trip to the Museum of Science, Harvard College Dean Evelynn M. Hammonds and students from her freshman seminar revisited many of the issues they explored in her fall class.
Daniel G. Kavanagh, a member of the faculty at the Ragon Institute, is one of the winners of the Bill & Melinda Gates Foundation’s Grand Challenges Explorations initiative.
He’s an economist, a researcher, and a physician, and he’s about to become provost. On the day (April 15) that President Drew Faust announced that he would be Harvard’s next provost, Alan M. Garber ’76 sat down with the Gazette to talk about his career, his new role, and facilitating connections across traditional academic boundaries as the University evolves for the 21st century.
Three technology proposals from the Harvard School of Engineering and Applied Sciences (SEAS) have been selected for presentation at the University Research and Entrepreneurship Symposium (URES).
The field of genomics, after revolutionizing crime fighting through DNA testing, is likely to shake the political landscape, says Jennifer Hochschild, who is researching its implications in Washington, D.C.
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced on Feb. 4 that its founding director, Donald E. Ingber, has been inducted into the American Institute for Medical and Biological Engineering’s College of Fellows.
Cancer geneticist Pier Paolo Pandolfi at Harvard-affiliated Beth Israel Deaconess Medical Center is the recipient of the 2011 Pezcoller Foundation-AACR International Award for Cancer Research.
Two fellowships in Harvard Medical School’s media fellowship program are open for applications from reporters.
Columbia University Medical Center presented the 2010 Naomi Berrie Award to Gökhan S. Hotamisligil, the James Stevens Simmons Professor of Genetics and Metabolism and the chair of the Department of Genetics and Complex Diseases at the Harvard School of Public Health.
Harvard doctoral candidate Alice Chen won first prize in the Collegiate Inventors Competition, while several other Harvard students took home second and third prizes.
Harvard Medical School and the Nancy Lurie Marks Family Foundation are accepting applications for the Nancy Lurie Marks Postdoctoral Fellowship in Autism. Two fellowships will be awarded, effective January 2011.
Applications are invited from graduate students who are writing dissertations or are engaged in major research on topics in practical ethics, especially ethical issues in architecture, business, education, government, law, medicine, public health, public policy, and religion.
This valuable handbook for new parents, written by McEvoy, an assistant professor of pediatrics at Harvard Medical School, offers evidence-based solutions and covers everything from spit-up to vaccinations.
Harvard Medical School Instructor in Anesthesia Wasim Malik has been awarded the Center for Integration of Medicine and Innovative Technology’s Miles and Eleanor Shore Fellowship for 2011.
Business neophytes at Harvard and MIT wrap up the annual case competition, stepping out of their everyday fields to learn about being business consultants.
Harvard Medical School released a series of revisions to its conflict of interest policy that strengthens its commitment to transparency and financial disclosure while recognizing the School’s commitment to industry collaboration.
Six Harvard affiliates have been named recipients of fellowships by the Damon Runyon Cancer Research Foundation, a nonprofit organization focused on supporting exceptional early-career researchers and innovative cancer research.
Nine rising seniors pursuing a secondary field in health policy have been awarded Cordeiro Health Policy Summer Research Grants by the Interfaculty Initiative in Health Policy.
Barely a month into the world as a new Harvard College graduate, Loren Galler Rabinowitz has already skyrocketed to success as the new Miss Massachusetts.
Assistant Professor of Stem Cell and Regenerative Biology Fernando Camargo, Assistant Professor of Pathology at Harvard Medical School (HMS) Alexander Gimelbrant, and Sun Hur, assistant professor of biological chemistry and molecular pharmacology at HMS, have been named 2010 Pew Scholars in the biomedical sciences by the Pew Charitable Trusts.
Harvey Goldman, professor of pathology at Harvard Medical School and the Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, died on April 6, 2009, from complications of a hematologic disorder. Goldman was not only a master educator, but also an outstanding surgical pathologist and investigator in the field of gastrointestinal pathology.
William “Bill” Avison Meissner, former Harvard Medical School clinical professor of pathology and emeritus professor of pathology at the New England Deaconess Hospital, died on Dec. 6, 2008, at age 95. Meissner’s expertise was in thyroid, soft tissue, and oropharyngeal tumors.
Paul Charles Zamecnik, the Collis P. Huntington Professor of Oncologic Medicine Emeritus, died in Boston on Oct. 27, 2009, at the age of 96. During a research career that spanned more than 70 years, he made a series of scientific contributions that represented multiple fields of biochemistry and molecular biology.
A diverse Harvard panel marks the 1910 death of William James, celebrates his life, and revisits his famous question.
Daniel Carpenter’s new book, “Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA,” probes the workings of a crucial federal safety agency that often is either lionized or demonized.